Literature DB >> 12527991

Abnormalities of cortical excitability and cortical inhibition in cervical dystonia Evidence from somatosensory evoked potentials and paired transcranial magnetic stimulation recordings.

Petr Kanovský1, Martin Bares, Hana Streitová, Hana Klajblová, Pavel Daniel, Ivan Rektor.   

Abstract

Cortical excitability and cortico-cortical inhibition were examined in twenty-one patients suffering from idiopathic rotational cervical dystonia. Polymyography of cervical muscles, somatosensory evoked potential recordings, and paired transcranial magnetic stimulation were used to assess the dystonic disorder. The results were compared with those obtained in a group of sixteen healthy age-matched volunteers. Statistically significant differences between the patient group and the control group were found when the amplitude values of the mean P22/N30 component measured at F [3, 4] and C[3, 4]' electrode positions were compared. The mean amplitude of P22/N30 in both of these electrode positions contralaterally to the direction of head deviation was significantly higher in the patient group (p <or= 0.05). The mean side-to-side P22/N30 amplitude ratio was calculated in both groups in the F[3, 4] and C[3, 4]' electrode positions: there was a significant difference between the two groups. The mean ratio (calculated contralaterally/ipsilaterally in the patient group and left/right side in the control group) was significantly higher in the patient group (p <or= 0.05). There were statistically significant differences between the two groups when the mean values of MEP amplitudes following paired stimuli at short and medium interstimulus intervals (ISI)) were compared. The percentage of amplitude reduction registered at short ISI was significantly lower in the patient group when both 3 ms ISI and 5 ms ISI were considered, and when the hemisphere contralateral to the direction of head deviation was stimulated. There was also a difference (with the short ISI) when the hemisphere ipsilateral to the direction of head deviation was stimulated, but this difference was not significant (p < 0.5). Almost all of the amplitude changes following the paired stimulus at the longer ISI, i. e. 10, 15, and 20 ms were significantly different when the patient group was compared with control group: when the ipsilateral hemisphere was stimulated, the amplitude of conditioned responses was significantly higher following all three paired stimuli (with 10, 15, and 20 ms ISI) at the p <or= 0.05 significance level; when the contralateral hemisphere was stimulated, they were significantly higher following the 10 and 20 ms ISI paired stimuli (significance level p <or= 0.05). The interhemispheric difference in the patient group was significant only for the paired stimuli using 3 and 5 ms (short) ISI and 15 and 20 ms (medium) ISI. There was a significantly decreased inhibition at 3 and 5 ms ISI when the hemisphere contralateral to the direction of head deviation was stimulated, as compared with the hemisphere ipsilateral (p <or= 0.05). Similarly, there was a significantly increased facilitation at 15 and 20 ms when the hemisphere contralateral to the direction of head deviation was stimulated, as compared with the hemisphere ipsilateral (p <or= 0.05). The results indicate that a disorder of both cortical excitability and intracortical inhibition exists in patients with cervical dystonia, and that this disorder is lateralized, i. e. it is located within the hemisphere contralateral to the direction of head deviation.

Entities:  

Mesh:

Year:  2003        PMID: 12527991     DOI: 10.1007/s00415-003-0942-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  Is the cerebellum a potential target for stimulation in Parkinson's disease? Results of 1-Hz rTMS on upper limb motor tasks.

Authors:  Eduard Minks; Radek Mareček; Tomáš Pavlík; Petra Ovesná; Martin Bareš
Journal:  Cerebellum       Date:  2011-12       Impact factor: 3.847

Review 2.  Botulinum toxin type A versus anticholinergics for cervical dystonia.

Authors:  J Costa; C Espírito-Santo; A Borges; J J Ferreira; M Coelho; C Sampaio
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 3.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

4.  Impaired Limb Proprioception in Adults With Spasmodic Dysphonia.

Authors:  Jürgen Konczak; Joshua E Aman; Yu-Wen Chen; Kuan-yi Li; Peter J Watson
Journal:  J Voice       Date:  2015-02-27       Impact factor: 2.009

5.  Enhanced dorsal premotor-motor inhibition in cervical dystonia.

Authors:  Sarah Pirio Richardson
Journal:  Clin Neurophysiol       Date:  2014-10-25       Impact factor: 3.708

Review 6.  Contemporary clinical neurophysiology applications in dystonia.

Authors:  Petr Kaňovský; Raymond Rosales; Pavel Otruba; Martin Nevrlý; Lenka Hvizdošová; Robert Opavský; Michaela Kaiserová; Pavel Hok; Kateřina Menšíková; Petr Hluštík; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2021-02-16       Impact factor: 3.575

7.  The clinical phenomenology and associations of trick maneuvers in cervical dystonia.

Authors:  Pavel Filip; Rastislav Šumec; Marek Baláž; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2015-12-08       Impact factor: 3.575

8.  Botulinum toxin injections reduce associative plasticity in patients with primary dystonia.

Authors:  Maja Kojovic; Antonio Caronni; Matteo Bologna; John C Rothwell; Kailash P Bhatia; Mark J Edwards
Journal:  Mov Disord       Date:  2011-04-05       Impact factor: 10.338

9.  Focal dystonia in musicians: linking motor symptoms to somatosensory dysfunction.

Authors:  Jürgen Konczak; Giovanni Abbruzzese
Journal:  Front Hum Neurosci       Date:  2013-06-25       Impact factor: 3.169

10.  The mechanisms of movement control and time estimation in cervical dystonia patients.

Authors:  Pavel Filip; Ovidiu V Lungu; Daniel J Shaw; Tomas Kasparek; Martin Bareš
Journal:  Neural Plast       Date:  2013-10-01       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.